An opportunity to impact the future of medicine

As told by Leah, Be The Match BioTherapies® allogeneic donor

Industry stakeholders propose unified CAR T toxicity grading scale

CIBMTR Cellular Therapy Registry recommended to meet outcomes data reporting requirements

Cell Lines In-the-News: June 2018

The Expanding Potential of Cord Blood

CAR-T 2.0

The quest to develop allogeneic CAR-T therapies

In-the-News: April 2018

Q&A With Be The Match BioTherapies Medical Director, Dr. Steven Devine

Part 2